Technical Analysis for BCDA - BioCardia, Inc.

Grade Last Price % Change Price Change
F 2.39 2.58% 0.06
BCDA closed up 2.58 percent on Friday, November 1, 2024, on 2 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 6
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Down 3 Days in a Row Weakness 2.58%
Lower Bollinger Band Touch Weakness 2.58%
Oversold Stochastic Weakness 2.58%
Stochastic Reached Oversold Weakness 0.84%
Oversold Stochastic Weakness 0.84%
180 Bearish Setup Bearish Swing Setup -1.24%
Oversold Stochastic Weakness -1.24%

   Recent Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia. The company is also developing CardiALLO Cell Therapy System, an investigational culture expanded bone marrow derived from mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system; and Morph vascular access product line, which provides catheter products. BioCardia, Inc. is based in San Carlos, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Bone Stem Cell Cell Therapy Catheter Cardiovascular Disease Heart Failure Vascular Disease Regenerative Medicine Heart Disease Vascular Access Products Aging Associated Diseases Bone Marrow Ischemia Treatment Of Heart Failure

Is BCDA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 23.25
52 Week Low 1.9562
Average Volume 1,038,071
200-Day Moving Average 4.42
50-Day Moving Average 2.67
20-Day Moving Average 2.55
10-Day Moving Average 2.47
Average True Range 0.21
RSI (14) 43.18
ADX 11.41
+DI 20.07
-DI 18.75
Chandelier Exit (Long, 3 ATRs) 2.27
Chandelier Exit (Short, 3 ATRs) 2.94
Upper Bollinger Bands 2.81
Lower Bollinger Band 2.30
Percent B (%b) 0.18
BandWidth 19.88
MACD Line -0.09
MACD Signal Line -0.08
MACD Histogram -0.0188
Fundamentals Value
Market Cap 56.45 Million
Num Shares 23.6 Million
EPS -0.62
Price-to-Earnings (P/E) Ratio -3.85
Price-to-Sales 17.62
Price-to-Book 10.67
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.54
Resistance 3 (R3) 2.54 2.49 2.52
Resistance 2 (R2) 2.49 2.45 2.49 2.51
Resistance 1 (R1) 2.44 2.42 2.44 2.44 2.50
Pivot Point 2.38 2.38 2.39 2.39 2.38
Support 1 (S1) 2.34 2.35 2.34 2.34 2.28
Support 2 (S2) 2.28 2.32 2.28 2.27
Support 3 (S3) 2.23 2.28 2.26
Support 4 (S4) 2.24